Pancreatic Cancer Research

ResearcherKyoto Prefectural University of MedicineActive in the last 2 years

Atsushi Shiozaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3739-160X; OpenAlex author ID A5017095541. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 3 papers · 2025: none · 2026: 3 papers

Papers 15

  1. Rising Pancreatic Cancer Incidence in Young Japanese Women and Increasing Distal Pancreatectomy in Older Adults: A Nationwide Claims-Based Analysis From 2016 t… Last author DOI 10.1002/ags3.70178↗
  2. Acidic microenvironment promotes pancreatic cancer cell survival via Akt phosphorylation-mediated suppression of apoptosis. Co-author DOI 10.3389/fonc.2026.1889708↗
  3. [Resection of Borderline Resectable Pancreatic Cancer with Arterial Involvement Following a Marked Response to Neoadjuvant Chemotherapy-A Case Report]. Last author PMID 42723240↗
  4. Cancer-Derived Small Extracellular Vesicles Affect Vascular Endothelial Cells and Promote Adhesiveness of Pancreatic Cancer Cells. Co-author DOI 10.1097/mpa.0000000000002346↗
  5. Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma. Co-author DOI 10.1186/s12885-024-12676-x↗
  6. Depletion of DNTTIP2 Induces Cell Cycle Arrest in Pancreatic Cancer Cells. First author DOI 10.21873/cgp.20426↗
  7. Roles of voltage‑gated potassium channels in the maintenance of pancreatic cancer stem cells. Co-author DOI 10.3892/ijo.2021.5256↗
  8. Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer. Co-author DOI 10.1038/s41598-017-06137-8↗
  9. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. Co-author DOI 10.3748/wjg.v22.i25.5627↗
  10. Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer. Co-author DOI 10.1038/bjc.2015.366↗
  11. Optimal duration of the early and late recurrence of pancreatic cancer after pancreatectomy based on the difference in the prognosis. Co-author DOI 10.1016/j.pan.2014.09.006↗
  12. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer. Co-author PMID 24778048↗
  13. Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer. Co-author DOI 10.1038/bjc.2012.546↗
  14. Enhancement of the cytocidal effects of hypotonic solution using a chloride channel blocker in pancreatic cancer cells. First author DOI 10.1016/j.pan.2012.08.003↗
  15. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Co-author DOI 10.1038/bjc.2011.453↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ryo Morimura · 11 shared papers, 2011–2026 · strength 1.08
  2. Taisuke Imamura · 6 shared papers, 2015–2026 · strength 0.86
  3. Eigo Otsuji · 11 shared papers, 2011–2024 · strength 0.78
  4. Eishi Ashihara · 2 shared papers, 2024–2026 · strength 0.75
  5. Hidemasa Kubo · 2 shared papers, 2026 · strength 0.52
  6. Raito Yamamoto · 1 shared paper, 2026 · strength 0.39
  7. Masato Yoshizawa · 1 shared paper, 2024 · strength 0.36
  8. Daisuke Ichikawa · 8 shared papers, 2011–2017 · strength 0.30
  9. Masamitsu Kido · 1 shared paper, 2026 · strength 0.28
  10. Yusuke Yamamoto · 3 shared papers, 2014–2024 · strength 0.26
  11. Goshi Takayama · 1 shared paper, 2026 · strength 0.24
  12. Hirotaka Furuke · 1 shared paper, 2024 · strength 0.18
  13. Jun Shibamoto · 1 shared paper, 2024 · strength 0.18
  14. Mahito Miyamae · 3 shared papers, 2015–2017 · strength 0.15
  15. Tsutomu Kawaguchi · 3 shared papers, 2013–2016 · strength 0.12
  16. Yoshito Nako · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.